Govt scraps import duty on Tamiflu

Image
Press Trust of India New Delhi
Last Updated : Jan 19 2013 | 11:47 PM IST

The government today exempted Tamiflu, drug used for the treatment of H1N1 Influenza (swine flu) from customs duty allowing duty free import of 10 lakh capsules of the medicine.

Tamiflu, a patented drug of Swiss pharmaceutical major Roche, is the only available medicine against H1N1 influenza known as swine flu.

According to an official statement, Roche India has been allowed to import 10 lakh capsule of Tamiflu 75 mg (Oseltamivir Phosphate).

"As part of the effort to create a buffer stock of the drug, Oseltamivir Phosphate, used for the treatment of H1N1 influenza, government has decided that the drug would be imported by Roche India to supplement the stock manufactured in India," an official statement said.

The Central Board of Excise and Customs has issued an exemption order for duty free import of one million capsules of Tamiflu in 75 mg strength, it said.

The duty exemption order has been issued on the recommendation of the Department of Health and Family Welfare.

The government has earlier said that it would maintained a stock pile of three million capsules of the drug and has already placed orders for the purchase.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: May 27 2009 | 3:37 PM IST

Next Story